CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma
26 participantsStarted 2009-01
Plain-language summary
This study will evaluate a uniform chemotherapy protocol for nonmetastatic extraocular retinoblastoma
Who can participate
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* IRSS stage II or stage IIIa RB patients.
* for patients with IRSS stage II disease, if scleral surface invasion alone was observed, only systemic chemotherapy was administered, whereas other IRSS stage II and IIIa patients received systemic chemotherapy plus additional local chemotherapy.
* no tumor-related treatment was given prior to this chemotherapy regimen.
Exclusion Criteria:
* metastasis, including lymph node metastasis.
* the diagnosis of IRSS stage I or above in the non-target eye.